Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 11/20 | 0.35 |
| ▸ | DBF4 | Q9UBU7 | 11/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SLC29A1 | Q99808 | 5/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22085125 | 0.85 | CDC7 (0.36) | CDC7DBF4ALDH1A1LMNAHPGD | |
| SCHEMBL22085316 | 0.84 | CDC7 (0.36) | CDC7DBF4ALDH1A1LMNAHPGD | |
| SCHEMBL22085123 | 0.83 | CDC7 (0.40) | CDC7DBF4ALDH1A1LMNAHPGD | |
| SCHEMBL22085126 | 0.83 | CXCR2 (0.41) | CDC7DBF4ALDH1A1LMNAHPGD | |
| SCHEMBL22084677 | 0.80 | CDC7 (0.38) | CDC7DBF4ALDH1A1LMNAHPGD | |
| SCHEMBL22084402 | 0.79 | CXCR2 (0.38) | CDC7DBF4HTT | |
| SCHEMBL22085315 | 0.78 | CDC7 (0.40) | CDC7DBF4ALDH1A1LMNAHPGD | |
| SCHEMBL22084401 | 0.77 | CDC7 (0.44) | CDC7DBF4ALDH1A1LMNAHPGD | |
| SCHEMBL22084679 | 0.77 | CDC7 (0.39) | CDC7DBF4ALDH1A1LMNAHPGD | |
| SCHEMBL22084400 | 0.77 | CDC7 (0.39) | CDC7DBF4ALDH1A1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020117938-A1 | PRODRUGS OF ANTI-CANCER AND ANTI-AUTOIMMUNE DISEASES THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2020-06-11 | — | — | WO | disclosed |